WKYC: "A smarter insulin, better meal timing and the avocado test"
Read More
Read More
Download article
June 9, 2026
View All
CareTalk Podcast: "Targeting the Root Causes of Metabolic Disease w/ Bob Geho, Founder & CEO, Diasome”
Read More
Read More
Download article
June 8, 2026
View All
Medscape Covers Diasome's OPTI-2 Liver-Directed Insulin Data from ADA 2026
Read More
Read More
Download article
June 7, 2026
View All
Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes
Read More
Read More
Download article
June 6, 2026
View All
OPTI-2 Trial Results Presented at ADA on June 7th at 5pm EST
Read More
Read More
Download article
May 26, 2026
View All
Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions
Read More
Read More
Download article
June 20, 2025
View All
Diasome Pharmaceuticals Completes Enrollment in Phase 2b OPTI-2 Trial of HDV-Insulin Lispro for Type 1 Diabetes
Read More
Read More
Download article
February 29, 2024
View All
Diasome Pharmaceuticals Launches Groundbreaking OPTI-2 Phase 2b Trial in Type 1 Diabetes
Read More
Read More
Download article
February 20, 2024
View All
Diasome Pharmaceuticals Appoints Peter Tollman, Ph.D., as Chairman of the Board
Read More
Read More
Download article
January 13, 2024
View All
Diasome Pharmaceuticals announces the addition of globally recognized biopharma thought leader and CEO advisor Peter Tollman, PhD as a new Board Member
Read More
Read More
Download article
December 7, 2023
View All
Diasome Pharmaceuticals Announces First Closing of Series C Financing Round
Read More
Read More
Download article
June 21, 2023
View All
Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions
